Underactive bladder (UAB) is a voiding dysfunction that has attracted much interest recently. In contrast to overactive bladder, UAB is commonly accepted as being part of the constellation of voiding lower urinary tract symptoms (LUTS), a symptom complex in patients with detrusor underactivity (DU) as shown by urodynamic study (UDS). To date, various research has been conducted on UAB, and many review articles have been published. Nevertheless, a consensus definition of UAB is still lacking, and the causes and symptoms of UAB are diverse. Moreover, a clear treatment policy is lacking. Thus, in this issue, we have attempted an in-depth review of six themes in UAB based on the literature reported to date.
The first review, "Definition and symptoms of underactive bladder" by Uren and Drake (Bristol, UK), summarizes the terminology and symptoms of UAB. Even though the International Continence Society (ICS) has defined DU, a plethora of terms are used to refer to DU. This may signify that the ICS definition alone is not sufficient to adequately distinguish patients. We can diagnose DU through UDS, but this type of diagnosis results in a wide variety of DU because no cutoff values have been established for UDS parameters in men and women. Uren and Drake introduce the definition of the ICS Working Group, which describes UAB as being characterized by a slow urinary stream, hesitancy, and straining to void, with or without a feeling of incomplete bladder emptying and dribbling, often with storage symptoms. The existing prevalence studies of UAB have been conducted in patients in whom UAB was diagnosed by UDS; thus, it is difficult to determine the exact prevalence of UAB in the community-dwelling population.
Yu and Jeong (Seongnam, Korea) review the results of several studies of patients with nonneurogenic LUTS concerning the limitations of the epidemiology study
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Editorial ⓒ The Korean Urological Association, 2017 mentioned above. Additionally, they suggest f uture directions for research in the epidemiologic study of UAB. They show that UAB can appear alone as a result of aging and can also be accompanied by various urologic diseases. Without an established treatment of DU, urologists might be uncertain as to whether to treat patients who have DU and other urologic disorders. On the basis of the review "Clinical implications of underactive bladder" by Ko et al. (Seoul, Korea), we believe that it is possible to present a solution for patients with DU and bladder outlet obstruction, overactive bladder, or urinary incontinence, which are common lower urinary tract dysfunctions.
Aizawa and Igawa (Tokyo, Japan) review the pathophysiology of UAB and present several hypotheses about the causes of UAB. They summarize the contributing factors to UAB as myogenic failure, efferent or afferent nerve dysfunction, and central nervous system failure. Several animal models have been used to identify these contributing factors to UAB. However, to date, treatment of UAB is limited, and no adequate oral medications are available. Kim (Daejeon, Korea) summarizes the pharmacologic and surgical treatments of UAB. Recently, the concepts of DU and UAB have been accepted in contemporary studies, but the biggest problem is that limitations remain in treatment and diagnosis. Chai and Kudze (CT, USA) proposes a departure from what is already known to "New therapeutic directions to treat the UAB."
As quality of life becomes more important and as society ages, the importance of UAB will increase, along with our interest in this voiding dysfunction. I hope this special issue will stimulate discussion of future research and help urologists to diagnose and treat patients with UAB. 
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